Better health is associated with a higher risk of heart disease.

Published Date: 17 Feb 2023

UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...

Read Full News

Todays Updates


AI Not Yet Ready for COPD Prognosis, With Jean Bourbeau, MD Jean Bourbeau, MD


AI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.

FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia


FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia

Brain Chat: Neck and Neck: A Race to the Right Diagnosis Mitzi Joi Williams, MD


Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.

NeurologyLive® Friday 5 — November 6, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.

ALS Agent Dazucorilant Associated With Lower 2-Year Mortality in Exploratory DAZALS Analysis Isabella Ciccone, MPH


Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.

NeurologyLive® Brain Games: November 8, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!

PrimeC Lowers Neuron-Derived TDP-43, Informing Phase 3 PARAGON Trial in ALS Isabella Ciccone, MPH


Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.

Todays Updates


AI Not Yet Ready for COPD Prognosis, With Jean Bourbeau, MD Jean Bourbeau, MD


AI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.

FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia


FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia

Brain Chat: Neck and Neck: A Race to the Right Diagnosis Mitzi Joi Williams, MD


Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.

NeurologyLive® Friday 5 — November 6, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.

ALS Agent Dazucorilant Associated With Lower 2-Year Mortality in Exploratory DAZALS Analysis Isabella Ciccone, MPH


Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.

NeurologyLive® Brain Games: November 8, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!

PrimeC Lowers Neuron-Derived TDP-43, Informing Phase 3 PARAGON Trial in ALS Isabella Ciccone, MPH


Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

2.

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

3.

Combo Therapy Boosts Early CML Response but Not Long Term

4.

Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes

5.

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot